The Norgestimate and Ethinyl Estradi, cataloged under National Stock Number 6505-01-662-6868, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-662-6868 |
| Primary Part Number | NDC00555-9016-58 |
| Item Name | Norgestimate and Ethinyl Estradi |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 28.0 TABLETS |
| Primary Container Type | CARD |
| Active Medicament Medicinal Strength | 0.25 MILLIGRAMS NORGESTIMATE ACTIVE INGREDIENT AND 0.35 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00555-9016-58 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1457806 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM173526 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-662-6868 is a Norgestimate and Ethinyl Estradi, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-662-6868 has 1 manufacturer part number on file: NDC00555-9016-58 (Teva Pharmaceuticals Usa, Inc.).
Key specifications for NDC00555-9016-58: Administration: ORAL; Primary Container Content Quantity: 28.0 TABLETS; Primary Container Type: CARD; Special Features: NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS; ORTHO-CYCLEN: 21 BLUE TABLETS CONTAIN 0.25MG NORGESTIMATE AND 0.35MG ETHINYL ESTRADIOL; 7 DARK GREEN TABLETS CONTAIN INERT INGREDIENTS; 28 TABLETS PER CYCLE, 6 CYCLES PER PACKAGE, TOTAL 168 TABLETS; STORE AT 25 C (77 F); EXCURSIONS PERMITTED TO 15-30 C (59 - 86 F). KEEP OUT OF THE REACH OF CHILDREN. PROTECT FROM LIGHT.. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.